Scarica l'app Stockscreener
2.20
8.33%
-0.20
Precedente Chiudi:
$2.40
Aprire:
$2.38
Volume 24 ore:
76,169
Relative Volume:
0.01
Capitalizzazione di mercato:
$1.95M
Reddito:
$232.00K
Utile/perdita netta:
$-12.13M
Rapporto P/E:
-0.2459
EPS:
-8.9454
Flusso di cassa netto:
$-10.29M
1 W Prestazione:
-21.43%
1M Prestazione:
+663.89%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.1584
$2.38
Intervallo di 1 settimana:
$2.1584
$2.9893
Portata 52W:
$0.1116
$3.87
Valion Bio Inc Stock (VBIO) Company Profile
Nome
Valion Bio Inc
Settore
Industria
Telefono
(888)276-6888
Indirizzo
1305 E. HOUSTON STREET, SAN ANTONIO
Compare VBIO vs MOBBW, PSNYW, GOODO, SHMD, CHAD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 0.00 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.395 | 1.79B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
4.14 | 698.19M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
19.67 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.23 | 226.24M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
8.07 | 197.39M | 0 | 0 | 0 | 0.00 |
Valion Bio Inc Borsa (VBIO) Ultime notizie
Investor group in Valion Bio (VBIO) shifts to passive stake - Stock Titan
Valion Bio Announces Changes to Management and Board of Directors - ACCESS Newswire
3i's $16.3M note in Valion Bio (VBIO) carries a 9.99% cap - Stock Titan
Aberdeen Income Credit Strategies Fund (ACP-PA) Peer Comparison – Compare with Others - Value Research
3i invests $7.7M in Valion Bio (VBIO) via preferreds and warrants - Stock Titan
Valion Bio (VBIO) Stock Analysis Report | Financials & Insights - Benzinga
Valion Bio appoints CFO Lisa Wolf as president, COO - TipRanks
Valion Bio's Ownership Structure Based on 32,140,634 Shares Outstanding (NASDAQ: VBIO) - Kalkine Media
Valion Bio Expands Lisa Wolf’s Role, Adds Two Board Directors - citybiz
Valion Bio names Lisa Wolf president and COO, adds directors - Investing.com
Valion Bio names Lisa Wolf president and COO, adds directors By Investing.com - Investing.com Nigeria
Valion Bio raises capital via new preferred financing - TipRanks
Valion Bio appoints Jared Malbin and Thomas Jensen to its board - TradingView
Valion Bio, Inc. Common Stock (VBIO) Financials 2026Income Statement and Balance Sheet - MarketBeat
Valion Bio Inc (VBIO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
3i group holds sub-10% Valion Bio (VBIO) stake with warrants, note - Stock Titan
Valion Bio Inc (VBIO) Peer Comparison – Compare with Others - valueresearchonline.com
Valion Bio Announces 1-for-25 Reverse Stock Split to Regain Nasdaq Compliance - Minichart
Valion Bio announces 1-for-25 reverse stock split By Investing.com - Investing.com Nigeria
Valion Bio Announces Reverse Stock Split - ACCESS Newswire
News by ACCESS Newswire on TradingView, 2026-08-27 - TradingView
Valion Bio Enacts Reverse Stock Split to Maintain Listing - TipRanks
Valion Bio (VBIO) holder nears 10% after big preferred swap - stocktitan.net
Valion Bio, Inc. SEC Filing (Aug 24, 2026) - Stock Titan
3i injects cash into Valion Bio (VBIO) under tight ownership cap - Stock Titan
Valion Bio Terminates CEO in Change of Corporate Leadership - Minichart
Form 8K Valion Bio Inc For: 17 August By Investing.com - Investing.com Nigeria
Valion Bio appoints new COO, terminates CEO, and announces funding agreements - Investing.com Canada
Valion Bio Secures New Series B Preferred Financing - TipRanks
Valion Bio Cash Plunges to $2.1M, Flags Going-Concern Risk - Minichart
Valion Bio (VBIO) investor group reports 1.74M shares, capped at 9.9% stake - Stock Titan
Valion Bio (OTC: VBIO) faces going concern risk and Nasdaq bid price warning - Stock Titan
Valion Bio, Inc. Q2 2026: Net loss $7.1M, EPS $(2.17) — 10-Q Summary - TradingView
Valion Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Entolimod Could Receive Its First National Registration in Ukraine - Stock Titan
Valion Bio, Inc. SEC Filing (Aug 13, 2026) - Stock Titan
Ukraine's Ministry Of Health Advances Entolimod Review Into Technical Assessment Phase - ACCESS Newswire
Valion Bio, Inc. (VBIO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Valion Bio Inc. (VBIO) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
Valion Bio Advances Government-Funded Entolimod Radiation Injury Studies With Data Expected in Early Fall - Yahoo Finance
Valion Bio begins safety study for radiation injury drug By Investing.com - Investing.com India
Valion Bio begins safety study for radiation injury drug - Investing.com
News by ACCESS Newswire on TradingView, 2026-08-12 - TradingView
Valion Bio Plans Mouse Study After Lethal Radiation Exposure - Stock Titan
Valion Bio, Inc. (OTC: VBIO) investors file 13D/A and outline $9M preferred stock plan - Stock Titan
Valion Bio, Inc.Common stock (Nasdaq:VBIO) Stock Quote - FinancialContent
Insiders Who Sold Valion Bio Missed Out On 19% Stock Increase - webull.com
Valion Bio Enters Securities Purchase Agreement With Avenue, Issues Preferred for $750,000 Milestone - tradingview.com
3i, LP Issues Letter to Valion Bio, Inc - marketscreener.com
Valion Bio Inc (NASDAQ: VBIO) Share Price, VBIO Stock News, VBIO Share Price & Updates - Kalkine
Murchinson Ltd. Acquires 440,242 Shares in Valion Bio Inc. - GuruFocus
Valion Bio Inc Azioni (VBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):